InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry G. Steele Buys 3,000 Shares

InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry G. Steele purchased 3,000 shares of InfuSystem stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $5.76 per share, with a total value of $17,280.00. Following the completion of the acquisition, the chief financial officer now owns 76,887 shares in the company, valued at $442,869.12. The trade was a 4.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

InfuSystem Stock Up 2.5%

INFU opened at $6.15 on Friday. The business has a 50 day moving average price of $5.27 and a 200 day moving average price of $7.13. InfuSystem Holdings, Inc. has a twelve month low of $4.61 and a twelve month high of $9.97. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The firm has a market cap of $129.25 million, a P/E ratio of 102.52 and a beta of 1.73.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of INFU. BNP Paribas Financial Markets lifted its holdings in shares of InfuSystem by 67.9% during the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company’s stock worth $58,000 after buying an additional 2,768 shares during the last quarter. Jump Financial LLC acquired a new position in shares of InfuSystem during the first quarter worth approximately $58,000. Wells Fargo & Company MN lifted its holdings in shares of InfuSystem by 51.7% during the fourth quarter. Wells Fargo & Company MN now owns 9,286 shares of the company’s stock worth $78,000 after buying an additional 3,165 shares during the last quarter. Legato Capital Management LLC acquired a new position in shares of InfuSystem during the fourth quarter worth approximately $85,000. Finally, Summit Global Investments acquired a new position in shares of InfuSystem during the fourth quarter worth approximately $86,000. 71.13% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. StockNews.com lowered InfuSystem from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Sidoti upgraded InfuSystem to a “strong-buy” rating in a report on Tuesday, March 18th. Finally, B. Riley upgraded InfuSystem to a “strong-buy” rating in a report on Thursday, May 8th.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.